Viewing Study NCT03704168


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2025-12-24 @ 5:37 PM
Study NCT ID: NCT03704168
Status: WITHDRAWN
Last Update Posted: 2021-11-29
First Post: 2018-02-23
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological Disorders
Sponsor: Dean Nakamoto
Organization:

Study Overview

Official Title: Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological Disorders.
Status: WITHDRAWN
Status Verified Date: 2021-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The study was never launched.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SECAMS
Brief Summary: To evaluate safety of cryoablation of submandibular glands in management of sialorrhea in neurologically impaired populations.

Secondary Objective: To evaluate efficacy of cryoablation of submandibular glands in management of sialorrhea in neurologically impaired populations.

Duration:

Estimation for Recruitment: 12 months Estimation for Procedure/Trial: 1 visit with an overnight observation Estimation for Subject Follow Up: 7 days, 14 days, 28 days, 90 days, and 180 days, post ablation, with ultrasound of the bilateral submandibular glands at 28 days and 180 days post ablation Total Expected Duration for Clinical Trial: 2 years
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: